Specialty chemicals & materials industry QUARTERLY REPORT

In 2023, the industry encountered significant challenges, with 68% of companies missing their initial guidance. The group of companies experienced a notable 13% decline in sales and a 21% drop in EBITDA. 

Key Topics Include:

• Q4 and Full-Year 2023 Results
• Competitive benchmarking
• Eight-quarter sales, volume, price, and profit trends
• Key markets and regional performance
• CEO perspectives
• 2024 Industry outlook
• M&A activities
• Industry capacity changes

Pricing Details:  

• Single-license digital copy in PDF: $500 USD 
• Enterprise-license digital copy in PDF: $1,000 USD  

To obtain your copy, please follow these steps:  

• Securely make your payment through the checkout below. 
• In the payment note field, kindly provide your full name, company name, and email address. 
•  You'll receive the report from info@creovgroup.com. Check your spam folder if not received within 24 hours.

In Q3 2023,  the industry faced yet another exceptionally challenging quarter, leading 50% of the companies we cover, which offer guidance, to revise their outlook downward.  At consolidated level, the group companies experienced a notable 13% decline in sales and a 18% drop in EBITDA. 

Key Topics Include:

• Q3 2023 revenue, price, volume and EBITDA performance
• Competitive benchmarking
• Seven-quarter sales, volume, price, and profit trends
• Key markets and regional performance
• CEO perspectives
• Q4 and full year 2023 outlook
• M&A activities
• Industry capacity changes

Pricing Details:  

• Single-license digital copy in PDF: $500 USD 
• Enterprise-license digital copy in PDF: $1,000 USD  

To obtain your copy, please follow these steps:  

• Securely make your payment through the checkout below. 
• In the payment note field, kindly provide your full name, company name, and email address. 
•  You'll receive the report from info@creovgroup.com. Check your spam folder if not received within 24 hours.

In Q2 2023, the industry grappled with significant challenges, experiencing a notable 17% decline in sales and a 29% drop in EBITDA. 

Key Highlights Include:

• Analysis of six-quarter sales, volume, price, and profit trends
• Examination of key market segment and regional performance
• Competitive benchmarking insights
• CEO perspectives
• 2023 industry outlook and potential risks
• Assessment of M&A activities
• Industry capacity changes

Pricing Details:  

• Single-license digital copy in PDF: $500 USD 
• Enterprise-license digital copy in PDF: $1,000 USD  

To obtain your copy, please follow these steps:  

• Securely make your payment through the checkout below. 
• In the payment note field, kindly provide your full name, company name, and email address. 
•  You'll receive the report from info@creovgroup.com. Check your spam folder if not received within 24 hours.

In Q1 2023, the Industry encountered notable challenges, witnessing a combined sales volume and EBITDA drop of 11% and 20%, respectively. 

• This report provides an industry-level perspective on sector performance, exploring key drivers, market trends, and highlighting areas of concern and opportunities. 
• It covers various crucial topics, including competitive  benchmarks, segment performance, destocking analysis, insights from CEOs, 2023 outlook, potential downside risks, and M&A activities. 
• The study involved a carefully chosen group of 21 public companies with a combined annual sales of $355 billion.
•  The report has received overwhelmingly positive feedback from industry stakeholders, including CEOs, business leaders, investors, analysts, and consultants 

Pricing Details:  

• Single-license digital copy in PDF: $35 USD 
• Enterprise-license digital copy in PDF: $100 USD  

To obtain your copy, please follow these steps:  

• Securely make your payment through the checkout below. 
• In the payment note field, kindly provide your full name, company name, and email address. 
•  You'll receive the report from info@creovgroup.com. Check your spam folder if not received within 24 hours.